Last Updated: Wednesday, December 25, 2013, 16:21
After selling its branded formulation business, Elder Pharma plans to focus on its anti-infectives' vertical and strengthen in-licence portfolio besides looking at expanding presence in global markets.
Last Updated: Sunday, April 07, 2013, 15:21
"We are looking at investment of Rs 15-20 crore over the next two-three years for marketing and manufacturing of cosmetics," Elder Pharmaceuticals Joint Managing Director Alok Saxena said here.
Last Updated: Sunday, November 25, 2012, 10:22
Elder Pharmaceuticals Ltd has said it is set to enter the regulated markets of European Union following the receipt of Certificate of Suitability (COS) from European Directorate for the Quality of Medicines and Healthcare (EDQM) for Diosmin API.
Last Updated: Monday, November 12, 2012, 18:44
Elder Pharma Monday said its consolidated net profit rose by 22 percent to Rs 23.60 crore in the July-September quarter.
more videos >>